Browse PDF – China Human Rabies Vaccine Industry, 2013-2017
facilities. Furthermore, the rabies tends to be further prevalent. At present, the first problem of China rabies control and prevention is the difficulty in dog management and vaccination implementation in the countryside. There are tens of millions of dogs in the countryside, but the rabies vaccination rate of dogs is less than 10%. Second, China lacks a coordination and management mechanism among departments involving in rabies control and prevention, which influences the improvement of overall rabies control and prevention effect.
Third, China does not establish a rabies immunologic barrier. In many rural areas, many people cannot be vaccinated in time after they are bitten by dogs, because of economic problems or poor medical facilities. Among people bitten by dogs in some rural areas, only 10%-20% of them are vaccinated with rabies vaccines.
In 2012, the lot release volume of rabies vaccines in China was 80.7425 million doses (about 16.15 million person-times), increasing by about 40% YOY. As human rabies vaccines belong to Vaccine II in China, people are vaccinated at their own expenses. Therefore, rabies vaccine is one of the human vaccines that have the largest market scale in China. The terminal market scale in 2012 was over CNY 5 billion.
For More Information Kindly Contact:
Browse Blog – http://latestmarketstudy.blogspot.com/